EyeTechCare raises $13M for ultrasound glaucoma treatment

March 13, 2013 by Brad Perriello

EyeTechCare raises nearly $13 million (€10 million) for a clinical trial of its EyeOP1 ultrasound device for treating glaucoma, aiming for a nod from U.S. regulators.


EyeTechCare said it landed nearly $13 million in its 3rd round of funding, aiming to use the cash to fund a clinical trial of its EyeOP1 ultrasound glaucoma treatment, which has been on the market in Europe since

Rillieux-la-Pape, France-based EyeTechCare said the backers include private investor Dr. Bernard Chauvin and prior investors Omnes Capital and France's SHAM insurance company.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.